Ethyl phosphoramidates of acyclovir: design, synthesis, molecular docking (HN Protein), and evaluation of antiviral and antioxidant activities
Autor: | Madhu Sudhana Saddala, Subba Rao Devineni, Madhava Golla, Naga Raju Chamarthi, Janardhan Avilala, Thaslim Basha Shaik, Narasimha Golla |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
chemistry.chemical_classification Antioxidant 010405 organic chemistry Chemistry Stereochemistry medicine.medical_treatment Organic Chemistry 01 natural sciences 0104 chemical sciences Nitric oxide Amino acid 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology Docking (molecular) medicine Phosphorylation HN Protein General Pharmacology Toxicology and Pharmaceutics Selectivity IC50 |
Zdroj: | Medicinal Chemistry Research. 26:999-1009 |
ISSN: | 1554-8120 1054-2523 |
DOI: | 10.1007/s00044-017-1819-8 |
Popis: | Synthesis of a series of new ethyl phosphoramidates 9a–j of acyclovir through phosphorylation of hydroxy group followed by substitution of numerous amines/amino acid esters 7a–j was accomplished. The structures of newly synthesized compounds were elucidated by spectroscopic data such as IR, NMR (1H, 13C, and 31P) and mass spectrophotometery, and elemental analyses. The synthesized products were screened for their antiviral activity against Newcastle disease virus, antioxidant potency by α, α-diphenyl-β-picrylhydrazyl free radical scavenging and nitric oxide radical scavenging methods, and antioxidant capacity by Ferric reducing antioxidant power method. The compound bearing 1-hydroxy 2-butylamine, 9c and amino acid ester derivatives, bonded with leucine methyl ester 9h and tyrosine methyl ester 9j were found to be potent inhibiters of Newcastle disease virus than that of acyclovir drug. The compounds, 9c (IC50 value, 22.5 ± 1.00 μg/mL), 9i (IC50 value, 21.5 ± 1.00 μg/mL) and 9j (IC50 value, 19.0 ± 1.50 μg/mL) were exhibited promising antioxidant activity while other compounds displayed moderate to good antioxidant activity. Docking study using molecular docking environment into haemaglutinin–neuraminidase protein has been carried out to find the potential selectivity and binding orientation of these new compounds into protein binding site. Interestingly, all the title compounds except 9a and 9g docked well into HN protein with considerable binding affinities better than that of acyclovir drug. |
Databáze: | OpenAIRE |
Externí odkaz: |